Keymed Biosciences’ US$400 Million Hong Kong IPO

O’Melveny & Myers and Cooley LLP advised Keymed Biosciences Inc. on the deal, while Kirkland & Ellis advised the joint sponsors and underwriters. Keymed Biosciences Inc….

This content is for members only.
Login to Read More Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for members only.
Login to Read More Join Now